Diagnosis of Human Immunodeficiency Virus Infection
- 19 December 2018
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 32 (1), e00064-18
- https://doi.org/10.1128/cmr.00064-18
Abstract
HIV diagnostics have played a central role in the remarkable progress in identifying, staging, initiating, and monitoring infected individuals on life-saving antiretroviral therapy. They are also useful in surveillance and outbreak responses, allowing for assessment of disease burden and identification of vulnerable populations and transmission “hot spots,” thus enabling planning, appropriate interventions, and allocation of appropriate funding. HIV diagnostics are critical in achieving epidemic control and require a hybrid of conventional laboratory-based diagnostic tests and new technologies, including point-of-care (POC) testing, to expand coverage, increase access, and positively impact patient management. In this review, we provide (i) a historical perspective on the evolution of HIV diagnostics (serologic and molecular) and their interplay with WHO normative guidelines, (ii) a description of the role of conventional and POC testing within the tiered laboratory diagnostic network, (iii) information on the evaluations and selection of appropriate diagnostics, (iv) a description of the quality management systems needed to ensure reliability of testing, and (v) strategies to increase access while reducing the time to return results to patients. Maintaining the central role of HIV diagnostics in programs requires periodic monitoring and optimization with quality assurance in order to inform adjustments or alignment to achieve epidemic control.Keywords
Funding Information
- President Emergency Plan for AIDS Relief
This publication has 283 references indexed in Scilit:
- HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 CountriesClinical Infectious Diseases, 2012
- HIV treatment as prevention and HPTN 052Current Opinion in HIV and AIDS, 2012
- Designing a genome-based HIV incidence assay with high sensitivity and specificityAIDS, 2011
- Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of InfectionClinical Infectious Diseases, 2011
- ‘Test-and-treat’: the end of the HIV epidemic?Current Opinion in Infectious Diseases, 2011
- Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in HaitiThe New England Journal of Medicine, 2010
- Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesThe Lancet, 2009
- Estimation of HIV Incidence in the United StatesJama-Journal Of The American Medical Association, 2008
- Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART StudyThe Journal of Infectious Diseases, 2008
- Development of a Rapid and Convenient Method for Determination of Rubella Virus-Specific Immunoglobulin G AvidityClinical and Vaccine Immunology, 2007